Bayer foresees dismal 2023 results amid inflation and deflated prices, invests US$65m in Ukraine operations

GERMANY- Drug and pesticide maker Bayer estimates that its 2023 results will likely come in at the lower end of its targeted range, jeopardized by cost inflation and a slump in prices of glyphosate-based weedkillers from last year’s highs, according to a report by Reuters. Bayer saw herbicide sales jump 44% in 2022 after Hurricane Ida damaged rival producers and…

Read More